Home » China to Pharma: Stop Foot-Dragging on New Vaccine GMP Certificates
China to Pharma: Stop Foot-Dragging on New Vaccine GMP Certificates
In the wake of a rash of infant deaths related to GMP-certified hepatitis B vaccines, China is renewing its push to have makers of vaccines, blood products and sterile injectables obtain a revised good manufacturing practice certificate.
International Pharmaceutical Regulatory Monitor
Drugs GMPs Regulatory AffairsInternational Pharmaceutical Regulatory Monitor
Upcoming Events
-
18Jul
-
21Oct